09/02/2025
4:07 PM | TransCode Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2025
8:55 PM | Anson Funds Management LP (Filed by)
TransCode Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/14/2025
3:15 PM | TransCode Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2025
1:16 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
TransCode Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/14/2025
3:15 PM | TransCode Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2025
3:20 PM | TransCode Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
3:40 PM | TransCode Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
3:41 PM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
04/16/2025
6:40 AM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
04/15/2025
3:38 PM | TransCode Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2025
7:15 AM | TransCode Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/25/2025
6:00 AM | TransCode Therapeutics (Filer)
| Form 424B5 | |
03/20/2025
4:16 PM | Tracy Thomas Joseph (Filed by)
TransCode Therapeutics (Subject)
| Form SCHEDULE 13D | |
02/25/2025
3:25 PM | TransCode Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:16 PM | Anson Funds Management LP (Filed by)
TransCode Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/04/2025
3:20 PM | TransCode Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
3:21 PM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
01/03/2025
6:25 PM | SABBY MANAGEMENT, LLC (Filed by)
TransCode Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/30/2024
4:08 PM | TransCode Therapeutics (Filer)
| Form DEF 14A | |
12/19/2024
3:48 PM | TransCode Therapeutics (Filer)
| Form PRE 14A | |
12/17/2024
11:15 PM | TransCode Therapeutics (Filer)
| Form EFFECT | |
12/12/2024
3:15 PM | TransCode Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/06/2024
4:05 PM | TransCode Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/02/2024
3:27 PM | TransCode Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
3:21 PM | TransCode Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
6:54 AM | TransCode Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:34 PM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
11/06/2024
3:05 PM | 3i, LP (Filed by)
TransCode Therapeutics (Subject)
| Form SC 13G/A | |
10/28/2024
3:02 PM | TransCode Therapeutics (Filer)
| Form DEF 14A | |
10/15/2024
4:23 PM | TransCode Therapeutics (Filer)
| Form PRE 14A | |
